002864.SZ · 盘龙药业
China A-shares · RS rating 9 · As of 2026-10-14
| Price | 20.45 CNY |
|---|---|
| 1-day change | -1.3% |
| RS rating (overall / 1M / 3M / 12M) | 9 / 55 / 11 / 23 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 17 / 9 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -10.1% |
| Distance from 52-week high | +47.8% |
| Market cap (USD) | $436.5M |